The Human Vaccines Project: A roadmap for cancer vaccine development
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Human Vaccines Project: A roadmap for cancer vaccine development
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 334, Pages 334ps9-334ps9
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-04-14
DOI
10.1126/scitranslmed.aaf0685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Why has active immunotherapy not worked in lung cancer?
- (2015) A. Thomas et al. ANNALS OF ONCOLOGY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences
- (2015) Petter Brodin et al. CELL
- Building the Human Vaccines Project: strategic management recommendations and summary report of the 15–16 July 2014 business workshop
- (2015) Theodore Schenkelberg et al. Expert Review of Vaccines
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- On-demand drug delivery from local depots
- (2015) Yevgeny Brudno et al. JOURNAL OF CONTROLLED RELEASE
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Global transcriptional characterization of CD8+ T cell memory
- (2015) Jan Böttcher et al. SEMINARS IN IMMUNOLOGY
- Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges
- (2015) Joseph Obeid et al. SEMINARS IN ONCOLOGY
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Trial Watch: Peptide-based anticancer vaccines
- (2015) Jonathan Pol et al. OncoImmunology
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
- (2014) T. C. van der Sluis et al. CLINICAL CANCER RESEARCH
- Improving DNA Vaccine Performance Through Vector Design
- (2014) James Williams CURRENT GENE THERAPY
- Deciphering the unusual HLA-A2/Melan-A/MART-1-specific TCR repertoire in humans
- (2014) Pedro Romero et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Misinitiation of intrathymicMART-1transcription and biased TCR usage explain the high frequency of MART-1-specific T cells
- (2014) Sheena Pinto et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli
- (2014) Darragh Duffy et al. IMMUNITY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Toward a Human Vaccines Project
- (2014) Wayne C Koff et al. NATURE IMMUNOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systems vaccinology: Probing humanity's diverse immune systems with vaccines
- (2014) B. Pulendran PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
- (2014) Howard L Kaufman et al. Journal for ImmunoTherapy of Cancer
- Adjuvants That Improve the Ratio of Antigen-Specific Effector to Regulatory T Cells Enhance Tumor Immunity
- (2013) R. Perret et al. CANCER RESEARCH
- Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
- (2013) Rodney A. Rosalia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Live-attenuatedListeria-based immunotherapy
- (2013) John Rothman et al. Expert Review of Vaccines
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
- (2013) Daniel T Utzschneider et al. NATURE IMMUNOLOGY
- Accelerating Next-Generation Vaccine Development for Global Disease Prevention
- (2013) W. C. Koff et al. SCIENCE
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Transcription Factor Foxo1 Represses T-bet-Mediated Effector Functions and Promotes Memory CD8+ T Cell Differentiation
- (2012) Rajesh R. Rao et al. IMMUNITY
- Understanding and learning from the success of prophylactic human papillomavirus vaccines
- (2012) John T. Schiller et al. NATURE REVIEWS MICROBIOLOGY
- DNA fusion vaccines enter the clinic
- (2011) Freda K. Stevenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
- (2011) J. Idoyaga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
- (2010) E. Klechevsky et al. BLOOD
- Designing CD8+ T cell vaccines: it's not rocket science (yet)
- (2010) Jonathan W Yewdell CURRENT OPINION IN IMMUNOLOGY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
- (2010) Daniel E. Speiser et al. SEMINARS IN IMMUNOLOGY
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Therapeutic vaccines in solid tumours: Can they be harmful?
- (2009) Alexander M.M. Eggermont EUROPEAN JOURNAL OF CANCER
- Enhancing CD8 T-cell memory by modulating fatty acid metabolism
- (2009) Erika L. Pearce et al. NATURE
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism
- (2008) J. Derbinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigens for cancer immunotherapy
- (2008) Michelle A. Neller et al. SEMINARS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started